But the stocks you mention do not have the qualities or quantities that ZYL has, so its a bit like comparing Apples with rice.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025